1-12 of 12
Agnès Buzyn, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Upper Age Limit for a Pediatric-Inspired Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL)? Analysis of the Graall-2005 Study

Françoise Huguet, MD, Thibaut Leguay, Xavier Thomas, MD PhD, Nicolas Boissel, MD PhD, Martine Escoffre-Barbe, MD, Patrice Chevallier, MD PhD, Mathilde Hunault, MD PhD, Norbert Vey, MD, Caroline Bonmati, MD, Stéphane Leprêtre, MD, Jean-Pierre Marolleau, MD PhD, Thomas Pabst, MD PhD, Philippe Rousselot, MD PhD, Agnès Buzyn, MD PhD, Jean-Yves Cahn, MD, Véronique Lhéritier, Marie C Béné, PharmD, PhD, Vahid Asnafi, MD PhD, Eric Delabesse, PharmD, PhD, Elizabeth Macintyre, MD PhD, Yves Chalandon, MD, Norbert Ifrah, Hervé Dombret, MD
Journal: Blood
Blood (2016) 128 (22): 762.
https://doi.org/10.1182/blood.V128.22.762.762
Published: 2016
Journal Articles

Intensive Care Management and Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Etienne Lengliné, MD, anne-Sophie Moreau, MD, Sylvie Chevret, MD, PhD, Frederic Pene, MD, PhD, François Blot, MD, Jean-Henri Bourhis, MD, Agnes Buzyn, MD, PhD, Benoît Schlemmer, MD, PhD, Gérard Socié, MD, PhD, Elie Azoulay, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4560.
https://doi.org/10.1182/blood.V122.21.4560.4560
Published: 2013
Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) for Chronic Myelomonocytic Leukemia (CMML): Prognostic Factors for Survival. A Report From the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC),

Sophie Park, Myriam Labopin, MD, MS, Ibrahim Yakoub-Agha, MD, PhD, Jacques Delaunay, Nathalie Dhedin, Agnes Buzyn, MD, PhD, Eric Deconinck, MD, PhD, Mauricette Michallet, Marie Robin, Thierry De Revel, MD, PhD, Marc Bernard, Norbert Vey, MD, Bruno Lioure, Simona Lapusan, Anne Sirvent, Reza Tabrizi, MD, Jean-Henri Bourhis, Christian Recher, MD, PhD, Yves Beguin, MD, PhD, Pierre Fenaux, MD, PhD, Mohamad Mohty
Journal: Blood
Blood (2011) 118 (21): 3794.
https://doi.org/10.1182/blood.V118.21.3794.3794
Published: 2011
Journal Articles

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Yvan Beaussant, Etienne Daguindau, MD, Aurore Vivot, Mohamad Mothy, MD, PhD, Herve Avet-Loiseau, MD, PhD, Damien Roos-Weil, MD, Mauricette Michallet, Nicole Raus, Didier Blaise, MD, Stephane Vigouroux, MD, Agnes Buzyn, MD, PhD, Gérard Socié, Nathalie Fegueux, Frederic Garban, MD, PhD, Eric Deconinck, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4113.
https://doi.org/10.1182/blood.V118.21.4113.4113
Published: 2011
Journal Articles

Allogeneic Stem Cell Transplantation for Blast Crisis (BC) Chronic Myelogenous Leukemia (CML) In the Tyrosine Kinase Inhibitors (TKIs) Era. Analysis of Pre-Transplant Variables on Transplant Outcome. On Behalf of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire and the French Group of CML

Franck Nicolini, MD, PhD, Laurent Modolo, Stat, Nicole Raus, Data, Noel Milpied, MD, Gerard Socie, MD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, Nathalie Fegueux, MD, Herve Tilly, MD, Didier Blaise, MD, Pierre Bordigoni, MD, Karin Bilger, MD, Catherine Cordonnier, Jean-Hugues Dalle, MD, PhD, Thierry De Revel, MD, PhD, Eric Deconninck, MD, Bernard Rio, MD, Anne Sirvent, Norbert Ifrah, MD, Gaelle Guillerm, MD, Valerie Mialou, Agnes Buzyn, MD, PhD, Anne Huynh, MD, Jacques-Olivier Bay, MD, PhD, Stephane Morisset, Stat., Mauricette Michallet
Journal: Blood
Blood (2010) 116 (21): 2266.
https://doi.org/10.1182/blood.V116.21.2266.2266
Published: 2010
Journal Articles

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Ambroise Marcais, Karin Bilger, MD, Raphael Porcher, Marie Robin, Mohamad Mohty, Mauricette Michalet, Didier Blaise, MD, Stephane Vigouroux, Pierre Bordigoni, Patrice Ceballos, Eric Deconinck, Nathalie Dehdin, Bernard Rio, MD, Jacques-Olivier Bay, MD, PhD, Cécile Pautas, Frederic Garban, Norbert Ifrah, Felipe Suarez, Gaelle Guillerm, MD, Nathalie Contentin, MD, Jean-Henri Bourhis, Marc Bernard, Jérôme Cornillon, Anne Huynh, MD, Ibrahim yakoub Agha, Anne Sirvent, Loic Fouillard, Agnes Buzyn, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2359.
https://doi.org/10.1182/blood.V116.21.2359.2359
Published: 2010
Journal Articles

Phase II Prospective Multicenter Study of Treosulfan Based Reduced Intensity Conditioning In Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Nathalie Tedone, CRA, Jacques-Olivier Bay, MD, PhD, Jean-Luc Harousseau, MD, PhD, Mohamad Mohty, Ibrahim Yakoub-Agha, MD, PhD, Agnes Buzyn, MD, PhD, Noel Milpied, MD, Franck E Nicolini, MD, PhD, Helene Labussiere, MD, Joachim Baumgart, PhD, Nicole Raus, Reza Tabrizi, MD, Didier Blaise, MD
Journal: Blood
Blood (2010) 116 (21): 2353.
https://doi.org/10.1182/blood.V116.21.2353.2353
Published: 2010
Journal Articles

NOTCH1/FBXW7 Mutations, but Not Low ERG/BAALC Expression, Identify a Major Subgroup of Adult T-ALL with a Favorable Outcome: a GRAALL Study.

Raouf Ben Abdelali, MD, Agnes Buzyn, MD, PhD, Vahid Asnafi, MD, PhD, Sandrine Le Noir, PhD, Norbert Ifrah, MD, PhD, Herve Dombret, MD, PhD, Elizabeth Macintyre, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1568.
https://doi.org/10.1182/blood.V114.22.1568.1568
Published: 2009
Journal Articles

Poor Outcome after Allogeneic Hematopoietic Stem Cell Transplantation for De Novo AML with Chromosome 7 Abnormalities: A Report for the ALWP of the European Group for Blood and Marrow Transplantation.

Agnes Buzyn, MD, PhD, Myriam Labopin, MD, Jurgen Finke, MD, Tapani Ruutu, MD, G. Ehninger, MD, Leo F. Verdonck, MD, Gerard Socie, MD, PhD, Roelof Willemze, MD, Karel Indrak, MD, Nigel H. Russell, MD, Vanderson Rocha, for the ALWP of the EBMT
Journal: Blood
Blood (2007) 110 (11): 325.
https://doi.org/10.1182/blood.V110.11.325.325
Published: 2007
Journal Articles

Depletion of Regulatory T Cells Dramatically Improves DC-Based Immunization Against Acute Myeloid Leukemia.

Stephanie Delluc, PhD, Auguste Gaston, Carmen Marchiol-Fournigault, Didier Fradelizi, MD-PhD, Armelle Regnault, PhD, Kim Hanh Le Quan Sang, PhD, Lea Tourneur, PhD, Gilles Chiocchia, PhD, Agnes Buzyn, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3694.
https://doi.org/10.1182/blood.V108.11.3694.3694
Published: 2006
Journal Articles

Prediction of Relapse Risk by Day 100 BCR-ABL Quantification after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukaemia.

Marie T. Rubio, MD, PhD, Vahid Asnafi, MD, Eric Delabesse, MD, PhD, Gandhi Damaj, MD, Nathalie Dhedin, MD, Bruno R. Varet, MD, Agnes Buzyn, MD, PhD, Elizabeth A. Macintyre, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2020.
https://doi.org/10.1182/blood.V106.11.2020.2020
Published: 2005
Journal Articles

Naturally Processed Peptides Eluted from Acute Myeloid Leukemia Cells : A Potent Antigen Source for Immunotherapy.

Stephanie Delluc, Lea Tourneur, PhD, Charlotte Boix, Anne-Sophie Michallet, MD, Bruno Varet, MD, Jean-Gerard Guillet, PhD, Agnes Buzyn, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1801.
https://doi.org/10.1182/blood.V104.11.1801.1801
Published: 2004